Turn Therapeutics (TTRX) Current Assets (2024 - 2026)

Turn Therapeutics has reported Current Assets for 3 years, with the latest figure at $11.5 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets changed N/A year-over-year to $11.5 million; the trailing twelve-month figure through Mar 2026 stood at $11.5 million (changed N/A YoY), and the FY2025 full-year result was $5.2 million, up 373.3% from the prior year.
• Current Assets for Q1 2026 stood at $11.5 million, up from $5.2 million in the prior quarter.
• The five-year high for Current Assets was $11.5 million in Q1 2026, with the low at $1.1 million in Q4 2024.
• Average Current Assets over 3 years is $5.3 million, with a median of $4.2 million recorded in 2025.
• Peak annual rise in Current Assets reached 373.3% in 2025, while the deepest fall reached 373.3% in 2025.
• Tracing TTRX's Current Assets over 3 years: stood at $1.1 million in 2024, then surged by 373.3% to $5.2 million in 2025, then surged by 120.4% to $11.5 million in 2026.
• The last three Current Assets figures came in at $11.5 million (Q1 2026), $5.2 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison